Premium
Pediatric hypervirulent Klebsiella pneumoniae septic arthritis
Author(s) -
Kishibe Shun,
Okubo Yusuke,
Morino Saeko,
Hirotaki Shintaro,
Tame Tomoyuki,
Aoki Kotaro,
Ishii Yoshikazu,
Ota Norikazu,
Shimomura Satoshi,
Sakakibara Hiroshi,
Terakawa Toshiro,
Horikoshi Yuho
Publication year - 2016
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/ped.12806
Subject(s) - medicine , klebsiella pneumoniae , septic arthritis , klebsiella , klebsiella infections , arthritis , microbiology and biotechnology , intensive care medicine , escherichia coli , biochemistry , chemistry , biology , gene
Cases of infection with hypervirulent Klebsiella pneumoniae are gradually increasing in number, and cause life‐threatening community‐acquired infection even in immunocompetent patients. A 14‐year‐old boy developed septic hip arthritis due to hypervirulent K . pneumoniae (sequence type 23, serotype K1, magA positive). The patient initially seemed to have been successfully treated with antibiotics and surgical intervention, but septic arthritis developed into osteomyelitis of the femoral head and myositis, which required long‐term antibiotic therapy and additional surgical intervention. This is the first pediatric case of hypervirulent K . pneumoniae septic hip arthritis. Treatment plans should mainly consist of antibiotic therapy and surgical intervention. Clinicians, even pediatricians, in developed countries should be aware of the increasing incidence of hypervirulent Klebsiella pneumoniae infection.